Pros-IT CNR: an Italian prostate cancer monitoring project

Marianna Noale, Stefania Maggi, Walter Artibani, Pier Francesco Bassi, Filippo Bertoni, Sergio Bracarda, Giario Natale Conti, Renzo Corvò, Mauro Gacci, Pierpaolo Graziotti, Stefano Maria Magrini, Riccardo Maurizi Enrici, Vincenzo Mirone, Rodolfo Montironi, Giovanni Muto, Stefano Pecoraro, Angelo Porreca, Umberto Ricardi, Andrea Tubaro, Vittorina ZagonelFiliberto Zattoni, Gaetano Crepaldi, Gaetano Crepaldi, Stefania Maggi, Marianna Noale, Angelo Porreca, Walter Artibani, Pier Francesco Bassi, Sergio Bracarda, Giario Natale Conti, Renzo Corvò, Pierpaolo Graziotti, Riccardo Maurizi Enrici, Vittorina Zagonel, Roberto Bortolus, Devis Collura, Franco Corbella, Nadia Di Muzio, Sara Falivene, Ilaria Ferrari, Matteo Ferro, Pietro Gabriele, Cinzia Iotti, Emanuele Montanari, Paolo Muto, Alessandro Parisi, Maria Paola Ruggieri, Matteo Giulio Spinelli, Luigi Squillace, Riccardo Valdagni, the Pros-IT CNR study group

Research output: Contribution to journalArticle


Aims: The Pros-IT CNR project aims to monitor a sample of Italian males ≥18 years of age who have been diagnosed in the participating centers with incident prostate cancer, by analyzing their clinical features, treatment protocols and outcome results in relation to quality of life. Methods: Pros-IT CNR is an observational, prospective, multicenter study. The National Research Council (CNR), Neuroscience Institute, Aging Branch (Padua) is the promoting center. Ninety-seven Italian centers located throughout Italy were involved. The field study began in September 1, 2014. Subjects eligible were diagnosed with biopsy-verified prostate cancer, naïve. A sample size of 1500 patients was contemplated. A baseline assessment including anamnestic data, clinical history, risk factors, the initial diagnosis, cancer staging information and quality of life (Italian UCLA Prostate Cancer Index; SF-12 Scale) was completed. Six months after the initial diagnosis, a second assessment evaluating the patient’s health status, the treatment carried out, and the quality of life will be made. A third assessment, evaluating the treatment follow-up and the quality of life, will be made 12 months after the initial diagnosis. The 4th, 5th, 6th and 7th assessments, similar to the third, will be completed 24, 36, 48 and 60 months after the initial diagnosis, respectively, and will include also a Food Frequency Questionnaire and the Physical Activity Scale for the Elderly. Discussion: The study will provide information on patients’ quality of life and its variations over time in relation to the treatments received for the prostate cancer.

Original languageEnglish
Pages (from-to)165-172
Number of pages8
JournalAging clinical and experimental research
Issue number2
Publication statusPublished - Apr 1 2017


  • Italian UCLA Cancer Index
  • Prostate cancer
  • Prostate cancer treatments
  • Quality of life
  • SF-12 Scale

ASJC Scopus subject areas

  • Ageing
  • Geriatrics and Gerontology

Fingerprint Dive into the research topics of 'Pros-IT CNR: an Italian prostate cancer monitoring project'. Together they form a unique fingerprint.

  • Cite this

    Noale, M., Maggi, S., Artibani, W., Bassi, P. F., Bertoni, F., Bracarda, S., Conti, G. N., Corvò, R., Gacci, M., Graziotti, P., Magrini, S. M., Maurizi Enrici, R., Mirone, V., Montironi, R., Muto, G., Pecoraro, S., Porreca, A., Ricardi, U., Tubaro, A., ... the Pros-IT CNR study group (2017). Pros-IT CNR: an Italian prostate cancer monitoring project. Aging clinical and experimental research, 29(2), 165-172.